» Articles » PMID: 16804046

Anti-Müllerian Hormone Levels in the Spontaneous Menstrual Cycle Do Not Show Substantial Fluctuation

Overview
Specialty Endocrinology
Date 2006 Jun 29
PMID 16804046
Citations 124
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Anti-Müllerian hormone (AMH), a quantitative marker for ovarian reserve, has been suggested to be independent of the classical endocrine fluctuations of the menstrual cycle.

Objective: The objective of the study was to determine whether AMH levels are constant throughout the menstrual cycle, compared with those of FSH, LH, and estradiol.

Design/patients: Frequent blood sampling was performed in 44 fertile, regularly cycling, female volunteers during one full menstrual cycle.

Setting: The study was conducted at a university hospital.

Main Outcome Measures: AMH, FSH, LH, and estradiol measurements were allocated to one of seven cycle phases, and a multilevel analysis was performed. Consistent fluctuation patterns were tested by fitting sine patterns to the data. Finally, the frequency in which randomly selected individual samples would remain in one of five preset level categories (quintiles) for each of the variables was studied.

Results: A sine pattern fitted to the AMH data was not statistically significant (P = 0.40). In contrast, sine patterns for FSH, LH, and estradiol were highly significant. Comparing the seven cycle phases, no significant differences could be observed between phase-specific AMH levels (P = 0.06). Repeated selection of AMH samples for each individual showed that in 71.5% of selections, AMH values remained in the same quintile, whereas in 27.9% values fell in an adjacent quintile.

Conclusions: AMH levels measured through a full menstrual cycle did not show consistent fluctuation patterns in contrast to levels of FSH, LH, and estradiol. Furthermore, random fluctuations were small, indicating that AMH can be relied on as a cycle-independent marker for ovarian reserve.

Citing Articles

Perspectives on biomarkers of reproductive aging for fertility and beyond.

Wang S, Ren J, Jing Y, Qu J, Liu G Nat Aging. 2024; 4(12):1697-1710.

PMID: 39672897 DOI: 10.1038/s43587-024-00770-5.


Inter-cycle variability of anti-Müllerian hormone: implications for predicting controlled ovarian stimulation cycle outcomes.

Sukur Y, Aslan B, Kaplan N, Dogru M, Ozmen B, Sonmezer M J Ovarian Res. 2024; 17(1):209.

PMID: 39456057 PMC: 11515343. DOI: 10.1186/s13048-024-01517-x.


Determination of Fertility Hormones and Adipokines by LC-MRM/MS Analysis.

Illiano A, Pinto G, Mallardo A, Melchiorre C, Serpico S, Varelli M ACS Omega. 2024; 9(33):35482-35489.

PMID: 39184469 PMC: 11339818. DOI: 10.1021/acsomega.4c02250.


Anti-Müllerian hormone and fertility in women after childhood cancer treatment: Association with current infertility risk classifications.

Nystrom A, Morse H, Ora I, Henic E, Engellau J, Wieslander E PLoS One. 2024; 19(8):e0308827.

PMID: 39133666 PMC: 11318921. DOI: 10.1371/journal.pone.0308827.


Elecsys AMH assay: Determination of Anti-Müllerian hormone levels and evaluation of the relationship between superovulation response in Holstein dairy cows.

Koca D, Aktar A, Turgut A, Sagirkaya H, Alcay S Vet Med Sci. 2024; 10(4):e1509.

PMID: 38889090 PMC: 11185223. DOI: 10.1002/vms3.1509.